Company intelligence / Profile preview
Phosprint
Athens, Greecephosprint.eu ↗
- Ownership
- Private
- Employees
- ~10
- Development stage
- Other
01
Overview
Phosprint is a Greek biotechnology company that develops advanced laser-assisted bioprinting (LAB) technology for tissue engineering and regenerative medicine. The company's proprietary platform allows for the high-resolution, high-speed printing of living cells and biomaterials with exceptional cell viability. Phosprint focuses on clinical applications such as skin regeneration for chronic wounds and the creation of complex 3D biological models for cancer research and drug screening. By bridging the gap between engineering and biology, the company aims to provide personalized medical solutions and accelerate the development of new therapies.
- Therapeutic areas
- OncologyDermatology
- Modalities
- DeviceCell therapy
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Beyond the preview
Go deeper on Phosprint.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Phosprint.